To describe the current status of using surfactant in the treatment of respiratory distress syndrome (RDS) in neonates at the National Hospital of Obstetrics and Gynecology. Materials and Methods: Retrospective descriptive study on the medical records of neonatal patients receiving surfactant from October 1, 2019 to December 31, 2019.